ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PROK vs RGNX // REVENUE GROWTH (YOY)

ProKidney Corp. (Class A) (NASDAQ) VS. REGENXBIO Inc. (NASDAQ) • 15-METRIC TALLY: PROK 0 — RGNX 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PROK VS. RGNX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PROK RGNX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) ACTIVE — 104.50% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 4/9 -3.00 RGNX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 47.4 49.6 -2.20 RGNX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $444.4M $489.2M -$44.7M RGNX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PROK REV RGNX REV PROK GROSS % RGNX GROSS % PROK FCF RGNX FCF
FY 2025 $0 $170.4M — — -$135.3M -$126.4M
FY 2024 $0 $83.3M — 59.7% -$155.9M -$175.6M
FY 2023 $0 $90.2M — — -$90.1M -$218.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PROK // BETA —
RGNX // BETA —